Cargando…

Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms

A total of 63 myeloproliferative neoplasms [MPN; 9 polycythemia vera (PV), 32 essential thrombocythemia (ET), and 22 myelofibrosis (MF)] underwent spleen stiffness (SS) measurement by vibration-controlled transient elastography equipped with a novel spleen-dedicated module. Higher SS values signific...

Descripción completa

Detalles Bibliográficos
Autores principales: Moia, Riccardo, Cittone, Micol Giulia, Boggione, Paola, Manfredi, Giulia Francesca, Favini, Chiara, Awikeh, Bassel, Pedrinelli, Anita Rebecca, Mahmoud, Abdurraouf Mokhtar, Nicolosi, Maura, Bellan, Mattia, Sainaghi, Pier Paolo, Pirisi, Mario, Gaidano, Gianluca, Patriarca, Andrea, Rigamonti, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576346/
https://www.ncbi.nlm.nih.gov/pubmed/34765563
http://dx.doi.org/10.3389/fonc.2021.777730
_version_ 1784595857900830720
author Moia, Riccardo
Cittone, Micol Giulia
Boggione, Paola
Manfredi, Giulia Francesca
Favini, Chiara
Awikeh, Bassel
Pedrinelli, Anita Rebecca
Mahmoud, Abdurraouf Mokhtar
Nicolosi, Maura
Bellan, Mattia
Sainaghi, Pier Paolo
Pirisi, Mario
Gaidano, Gianluca
Patriarca, Andrea
Rigamonti, Cristina
author_facet Moia, Riccardo
Cittone, Micol Giulia
Boggione, Paola
Manfredi, Giulia Francesca
Favini, Chiara
Awikeh, Bassel
Pedrinelli, Anita Rebecca
Mahmoud, Abdurraouf Mokhtar
Nicolosi, Maura
Bellan, Mattia
Sainaghi, Pier Paolo
Pirisi, Mario
Gaidano, Gianluca
Patriarca, Andrea
Rigamonti, Cristina
author_sort Moia, Riccardo
collection PubMed
description A total of 63 myeloproliferative neoplasms [MPN; 9 polycythemia vera (PV), 32 essential thrombocythemia (ET), and 22 myelofibrosis (MF)] underwent spleen stiffness (SS) measurement by vibration-controlled transient elastography equipped with a novel spleen-dedicated module. Higher SS values significantly correlated with grade 2-3 bone marrow (BM) fibrosis (p=0.035), with hemoglobin level <10 g/dl (p=0.014) and with white blood cells ≥10,000/μl (p=0.008). Median SS was significantly higher in MF patients compared to ET and PV (p=0.015). SS also correlated with higher JAK2 variant allele frequency (p=0.02). This study identifies SS as a potential noninvasive tool that reflects BM fibrosis and the mutational burden in MPN.
format Online
Article
Text
id pubmed-8576346
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85763462021-11-10 Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms Moia, Riccardo Cittone, Micol Giulia Boggione, Paola Manfredi, Giulia Francesca Favini, Chiara Awikeh, Bassel Pedrinelli, Anita Rebecca Mahmoud, Abdurraouf Mokhtar Nicolosi, Maura Bellan, Mattia Sainaghi, Pier Paolo Pirisi, Mario Gaidano, Gianluca Patriarca, Andrea Rigamonti, Cristina Front Oncol Oncology A total of 63 myeloproliferative neoplasms [MPN; 9 polycythemia vera (PV), 32 essential thrombocythemia (ET), and 22 myelofibrosis (MF)] underwent spleen stiffness (SS) measurement by vibration-controlled transient elastography equipped with a novel spleen-dedicated module. Higher SS values significantly correlated with grade 2-3 bone marrow (BM) fibrosis (p=0.035), with hemoglobin level <10 g/dl (p=0.014) and with white blood cells ≥10,000/μl (p=0.008). Median SS was significantly higher in MF patients compared to ET and PV (p=0.015). SS also correlated with higher JAK2 variant allele frequency (p=0.02). This study identifies SS as a potential noninvasive tool that reflects BM fibrosis and the mutational burden in MPN. Frontiers Media S.A. 2021-10-26 /pmc/articles/PMC8576346/ /pubmed/34765563 http://dx.doi.org/10.3389/fonc.2021.777730 Text en Copyright © 2021 Moia, Cittone, Boggione, Manfredi, Favini, Awikeh, Pedrinelli, Mahmoud, Nicolosi, Bellan, Sainaghi, Pirisi, Gaidano, Patriarca and Rigamonti https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Moia, Riccardo
Cittone, Micol Giulia
Boggione, Paola
Manfredi, Giulia Francesca
Favini, Chiara
Awikeh, Bassel
Pedrinelli, Anita Rebecca
Mahmoud, Abdurraouf Mokhtar
Nicolosi, Maura
Bellan, Mattia
Sainaghi, Pier Paolo
Pirisi, Mario
Gaidano, Gianluca
Patriarca, Andrea
Rigamonti, Cristina
Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms
title Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms
title_full Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms
title_fullStr Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms
title_full_unstemmed Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms
title_short Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms
title_sort stiffer spleen predicts higher bone marrow fibrosis and higher jak2 allele burden in patients with myeloproliferative neoplasms
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576346/
https://www.ncbi.nlm.nih.gov/pubmed/34765563
http://dx.doi.org/10.3389/fonc.2021.777730
work_keys_str_mv AT moiariccardo stifferspleenpredictshigherbonemarrowfibrosisandhigherjak2alleleburdeninpatientswithmyeloproliferativeneoplasms
AT cittonemicolgiulia stifferspleenpredictshigherbonemarrowfibrosisandhigherjak2alleleburdeninpatientswithmyeloproliferativeneoplasms
AT boggionepaola stifferspleenpredictshigherbonemarrowfibrosisandhigherjak2alleleburdeninpatientswithmyeloproliferativeneoplasms
AT manfredigiuliafrancesca stifferspleenpredictshigherbonemarrowfibrosisandhigherjak2alleleburdeninpatientswithmyeloproliferativeneoplasms
AT favinichiara stifferspleenpredictshigherbonemarrowfibrosisandhigherjak2alleleburdeninpatientswithmyeloproliferativeneoplasms
AT awikehbassel stifferspleenpredictshigherbonemarrowfibrosisandhigherjak2alleleburdeninpatientswithmyeloproliferativeneoplasms
AT pedrinellianitarebecca stifferspleenpredictshigherbonemarrowfibrosisandhigherjak2alleleburdeninpatientswithmyeloproliferativeneoplasms
AT mahmoudabdurraoufmokhtar stifferspleenpredictshigherbonemarrowfibrosisandhigherjak2alleleburdeninpatientswithmyeloproliferativeneoplasms
AT nicolosimaura stifferspleenpredictshigherbonemarrowfibrosisandhigherjak2alleleburdeninpatientswithmyeloproliferativeneoplasms
AT bellanmattia stifferspleenpredictshigherbonemarrowfibrosisandhigherjak2alleleburdeninpatientswithmyeloproliferativeneoplasms
AT sainaghipierpaolo stifferspleenpredictshigherbonemarrowfibrosisandhigherjak2alleleburdeninpatientswithmyeloproliferativeneoplasms
AT pirisimario stifferspleenpredictshigherbonemarrowfibrosisandhigherjak2alleleburdeninpatientswithmyeloproliferativeneoplasms
AT gaidanogianluca stifferspleenpredictshigherbonemarrowfibrosisandhigherjak2alleleburdeninpatientswithmyeloproliferativeneoplasms
AT patriarcaandrea stifferspleenpredictshigherbonemarrowfibrosisandhigherjak2alleleburdeninpatientswithmyeloproliferativeneoplasms
AT rigamonticristina stifferspleenpredictshigherbonemarrowfibrosisandhigherjak2alleleburdeninpatientswithmyeloproliferativeneoplasms